109 related articles for article (PubMed ID: 15510463)
1. Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results).
Hussain N; Das T; Vashist U; Sumashri K
Indian J Ophthalmol; 2004 Sep; 52(3):227-31. PubMed ID: 15510463
[TBL] [Abstract][Full Text] [Related]
2. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
Verteporfin in Photodynamic Therapy Study Group
Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
Pece A; Isola V; VadalĂ M; Matranga D
Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
Ergun E; Heinzl H; Stur M
Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
Pece A; VadalĂ M; Isola V; Matranga D
Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
[TBL] [Abstract][Full Text] [Related]
15. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.
Ruiz-Moreno JM; Montero JA
Br J Ophthalmol; 2003 Jul; 87(7):856-9. PubMed ID: 12812885
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.
Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hara W; Yoshida T; Tokoro T; Mochizuki M
Am J Ophthalmol; 2008 Mar; 145(3):518-526. PubMed ID: 18207125
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
Cohen SY; Bulik A; Dubois L; Quentel G
Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
Soubrane G; Harding SP; Wolf S; Weichselberger A
Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]